| Total—CAD (40) | Total—non-CAD (30) | Adipose—CADa (16) | Adipose—non-CADa (13) |
---|---|---|---|---|
Age (years) | 60.9 ± 6.6 | 58.2 ± 6.3 | 59.6 ± 9.0 | 57.8 ± 6.4 |
Male (%) | 31 (77.5) | 17 (56.7) | 11 (68.8) | 7 (53.8) |
BMI (kg/m2) | 25.9 ± 2.9 | 24.7 ± 3.0 | 26.2 ± 2.0 | 24.5 ± 2.6 |
LVEF (%) | 58.1 ± 9.3 | 56.2 ± 9.5 | 62.0 ± 7.9 | 60.5 ± 5.7 |
Fasting glucose (mmol/L) | 6.2 (5.7, 7.8) | 5.4 (5.0, 6.5) | 6.6 (5.6, 7.5) | 6.2 (5.1, 8.1) |
Glycosylated serum protein (%) | 15.2 (13.8, 18.3) | 15.1 (13.8, 18.5) | 17.4 (13.4, 19.4) | 14.7 (13.6, 15.7) |
Fasting insulin(uU/mL) | 36.1 (24.4, 53.3) | 24.1 (13.4, 36.2) | 35.2 (18.8, 74.4) | 21.7 (14.0, 32.1) |
HOMA-IR | 9.8 (6.7, 15.2) | 6.1 (3.4, 10.0) | 9.0 (6.4, 26.2) | 5.1 (3.6, 9.6) |
Triglycerides (mmol/L) | 1.5 (1.0, 2.4) | 1.5 (1.0, 1.9) | 1.9 (1.1, 2.5) | 1.2 (0.7, 1.7) |
Total cholesterol (mmol/L) | 4.0 ± 1.1 | 4.7 ± 0.9* | 4.1 ± 1.1 | 4.6 ± 0.8 |
HDL-C (mmol/L) | 1.0 (0.8, 1.3) | 1.2 (0.9, 1.5) | 1.0 (0.8, 1.2) | 1.2 (0.8, 1.4) |
LDL-C (mmol/L) | 2.6 ± 0.9 | 3.2 ± 0.9* | 2.4 ± 0.9 | 2.8 ± 0.8 |
hsCRP (mg/L) | 1.8 (0.9, 3.1) | 1.3 (0.5, 4.0) | 2.2 (1.0, 3.0) | 1.2 (0.5, 3.0) |
SFRP4 (ng/mL) | 16.8 ± 3.3 | 14.5 ± 2.3** | 15.7 ± 3.2 | 13.3 ± 2.4¶ |
Hypertension (%) | 19 (47.5) | 9 (30.0) | 6 (37.5) | 5 (38.5) |
T2DM (%) | 14 (35.0) | 6 (20.0) | 7 (43.8) | 2 (15.4) |
Smoking (%) | 16 (40.0) | 7 (23.3) | 6 (37.5) | 2 (15.4) |
Aspirin (%) | 34 (85.0) | 4 (13.3)** | 13 (81.3) | 3 (23.1)§ |
Nitrates (%) | 38 (95.0) | 5 (16.7)** | 15 (93.8) | 3 (23.1)§ |
ACEI/ARB (%) | 14 (35.0) | 5 (16.7) | 4 (25.0) | 2 (15.4) |
Statins (%) | 23 (57.5) | 5 (16.7)** | 7 (43.8) | 1 (7.7)¶ |
β-Blockers (%) | 17 (42.5) | 6 (20.0) | 8 (50.0) | 3 (23.1) |
Calcium channel blockers (%) | 10 (25.0) | 2 (6.7) | 4 (25.0) | 1 (7.7) |
Hypoglycemic agents (%) | 13 (32.5) | 5 (16.7) | 7 (43.8) | 2 (15.4) |